
TY  - JOUR
AU  - Gonzalez-Fernandez, Tomas
AU  - Kelly, Daniel J.
AU  - O'Brien, Fergal J.
C7  - 1800038
TI  - Controlled Non-Viral Gene Delivery in Cartilage and Bone Repair: Current Strategies and Future Directions
JO  - Advanced Therapeutics
JA  - Adv. Therap.
VL  - 1
IS  - 7
UR  - https://doi.org/10.1002/adtp.201800038
DO  - doi:10.1002/adtp.201800038
SP  - 1800038
KW  - bones
KW  - cartilage
KW  - gene-activated scaffolds
KW  - non-viral gene delivery
KW  - orthopedic gene therapy
KW  - tissue engineering
PY  - 2018
AB  - Abstract Recent advances in the approval and commercialization of gene therapeutics have fostered the return of gene therapy to center stage. But despite new optimism, no Food and Drug Administration approved product exists for the treatment of orthopedic disorders. Non-viral gene delivery is a promising alternative to recombinant protein administration and viral gene transduction for orthopedic tissue engineering. When applied using appropriately designed systems, it enables temporal control of the overexpression of therapeutic genes, leading to local production of regulatory factors at physiologically relevant levels. Incorporating genetic material into 3D scaffold biomaterials, that is, gene activated scaffolds or hydrogels, presents a particular opportunity to utilize non-viral gene therapy for in situ transfection of host cells and the regeneration of damaged tissues and organs. But controlled non-viral gene delivery for musculoskeletal regeneration depends on a multifactorial design in which the choice of gene delivery method, therapeutic gene, and supportive biomaterial play a central role for the success of this strategy. This paper reviews the different modalities of non-viral gene delivery used for the repair of bone and cartilage, and explores the current challenges and opportunities for the engineering of functional orthopedic tissues using gene activated scaffolds.
ER  - 

TY  - JOUR
AU  - Shen, Bingyu
AU  - Zhao, Chenxu
AU  - Wang, Yue
AU  - Peng, Yi
AU  - Cheng, Jiaqi
AU  - Li, Zheng
AU  - Wu, Lin
AU  - Jin, Meiyu
AU  - Feng, Haihua
TI  - Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways
JO  - Journal of Cellular and Molecular Medicine
JA  - J Cell Mol Med
VL  - 23
IS  - 6
SN  - 1582-1838
UR  - https://doi.org/10.1111/jcmm.14293
DO  - doi:10.1111/jcmm.14293
SP  - 4063
EP  - 4075
KW  - Aucubin
KW  - NAFLD
KW  - Nrf2
KW  - tyloxapol
PY  - 2019
AB  - Abstract Aucubin (AU) is the main active ingredient of Aucuba japonica which has showed many positive effects such as anti-inflammation and liver protection. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. In this research, we explored the effects of AU on the tyloxapol-induced NAFLD in mice and apolipoprotein C-III (apoC-III) induced-3T3L1 cells. Tyloxapol (300 mg/kg) was injected to C57BL/6 mice with aucubin. The differentiated 3T3-L1 cells were treated with or without aucubin after stimulation of apoC-III (100 ?g/mL). In results, aucubin inhibited hyperlipidaemia, oxidative stress and inflammation by influencing the content of total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), very low density lipoprotein (VLDL), myeloperoxidase (MPO), superoxide dismutase (SOD), tumour necrosis factor receptor-α (TNF-α), interleukin-1? (IL-1?), and IL-6 in blood. AU activated NF-E2-related factor 2 (Nrf2), peroxisome proliferator-activated receptor α (PPARα), PPAR? and hemeoxygenase-1 (HO-1) and promoted the phosphorylation of adenosine 5?-monophosphate-activated protein kinase (AMPKα), AMPK?, acetyl-CoA carboxylase (ACC) and protein kinase B (AKT). In conclusion, AU performed the function of hypolipidaemic by its obvious anti-inflammation and antioxidant activity, which may become a kind of new drug targeting at NAFLD.
ER  - 

TY  - JOUR
AU  - Cuthbertson Sir, David P.
AU  - Zagreb Dr., Honoris Causa
TI  - The Metabolic Response to Injury and Its Nutritional Implications: Retrospect and Prospect
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 3
IS  - 3
SN  - 0148-6071
UR  - https://doi.org/10.1177/014860717900300302
DO  - doi:10.1177/014860717900300302
SP  - 108
EP  - 129
PY  - 1979
ER  - 

TY  - JOUR
TI  - P941 - P1197
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1429.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1429.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - ABSTRACTS: 1st International Conference on Therapeutic Risk Management & 19th International Conference on Pharmacoepidemiology, Philadelphia, Pennsylvania, USA, 21–24 August, 2003
JO  - Pharmacoepidemiology and Drug Safety
VL  - 12
IS  - S1
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.2003.12.s1.s1
DO  - doi:10.1002/pds.2003.12.s1.s1
SP  - S1
EP  - S189
PY  - 2003
ER  - 

TY  - JOUR
TI  - Posters
JO  - FEMS Microbiology Letters
VL  - 222
IS  - s1
SN  - 0378-1097
UR  - https://doi.org/10.1016/S0378-1097(03)00297-0
DO  - doi:10.1016/S0378-1097(03)00297-0
SP  - 103
EP  - 505
PY  - 2003
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Fundamental & Clinical Pharmacology
JA  - Fundam Clin Pharmacol
VL  - 27
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/fcp.12026
DO  - doi:10.1111/fcp.12026
SP  - 46
EP  - 127
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts Poster
JO  - American Journal of Transplantation
VL  - 8
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2008.02255.x
DO  - doi:10.1111/j.1600-6143.2008.02255.x
SP  - 337
EP  - 637
PY  - 2008
ER  - 

TY  - JOUR
AU  - Bandara, H. M. H. N.
AU  - Samaranayake, Lakshman P.
TI  - Viral, bacterial, and fungal infections of the oral mucosa: Types, incidence, predisposing factors, diagnostic algorithms, and management
JO  - Periodontology 2000
JA  - Periodontol 2000
VL  - 80
IS  - 1
SN  - 0906-6713
UR  - https://doi.org/10.1111/prd.12273
DO  - doi:10.1111/prd.12273
SP  - 148
EP  - 176
PY  - 2019
AB  - Abstract For millions of years, microbiota residing within us, including those in the oral cavity, coexisted in a harmonious symbiotic fashion that provided a quintessential foundation for human health. It is now clear that disruption of such a healthy relationship leading to microbial dysbiosis causes a wide array of infections, ranging from localized, mild, superficial infections to deep, disseminated life-threatening diseases. With recent advances in research, diagnostics, and improved surveillance we are witnessing an array of emerging and re-emerging oral infections and orofacial manifestations of systemic infections. Orofacial infections may cause significant discomfort to the patients and unnecessary economic burden. Thus, the early recognition of such infections is paramount for holistic patient management, and oral clinicians have a critical role in recognizing, diagnosing, managing, and preventing either new or old orofacial infections. This paper aims to provide an update on current understanding of well-established and emerging viral, bacterial, and fungal infections manifesting in the human oral cavity.
ER  - 

TY  - JOUR
TI  - ASBMR 19th annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 12
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650120103
DO  - doi:10.1002/jbmr.5650120103
SP  - S1
EP  - S531
PY  - 1997
ER  - 

TY  - JOUR
TI  - Index of biochemical reviews
JO  - FEBS Letters
VL  - 256
IS  - S1
SN  - 0014-5793
UR  - https://doi.org/10.1016/0014-5793(89)81702-8
DO  - doi:10.1016/0014-5793(89)81702-8
SP  - 1
EP  - 230
PY  - 1989
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 65
IS  - S1
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.14915
DO  - doi:10.1111/jgs.14915
SP  - S1
EP  - S289
PY  - 2017
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF ORAL PRESENTATIONS THIRD MEETING EUROPEAN ASSOCIATION OF VETERINARY DIAGNOSTIC IMAGING BERLIN, GERMANY SEPTEMBER 6–10,1995
JO  - Veterinary Radiology & Ultrasound
VL  - 36
IS  - 5
SN  - 1058-8183
UR  - https://doi.org/10.1111/j.1740-8261.1995.tb00289.x
DO  - doi:10.1111/j.1740-8261.1995.tb00289.x
SP  - 425
EP  - 442
PY  - 1995
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221404
DO  - doi:10.1002/jbmr.5650221404
SP  - s102
EP  - s151
PY  - 2007
ER  - 

AU  - Simpson, N. B.
AU  - Cunliffe, W. J.
C7  - pp. 2121-2196
TI  - Disorders of the Sebaceous Glands
SN  - 9780632064298
UR  - https://doi.org/10.1002/9780470750520.ch43
DO  - doi:10.1002/9780470750520.ch43
SP  - 2121-2196
KW  - seborrhoea
KW  - sebaceous glands
KW  - composition
KW  - hormonal disease
KW  - comedone formation
PY  - 2007
AB  - Summary This chapter contains section titled: Structure and distribution Acne vulgaris Aetiology of acne Clinical features Treatment Uncommon associations with acne Severe acne variants Ectopic sebaceous glands Sebaceous gland hyperplasia, adenoma and carcinoma ?Sebaceous? (epidermoid) cysts and steatocystoma multiplex
ER  - 

TY  - JOUR
TI  - ASBMR 22nd annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 15
IS  - S1
SN  - 9780632064298
UR  - https://doi.org/10.1002/jbmr.5650150102
DO  - doi:10.1002/jbmr.5650150102
SP  - S1
EP  - S584
PY  - 2000
ER  - 

C7  - pp. 1051-1518
TI  - French-English-German
SN  - 9783826334054
UR  - https://doi.org/10.1002/9780470760338.ch3
DO  - doi:10.1002/9780470760338.ch3
SP  - 1051-1518
PY  - 2000
AB  - Summary This chapter contains sections titled: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 36
IS  - s2
SN  - 9783826334054
UR  - https://doi.org/10.1111/j.1530-0277.2012.01917.x
DO  - doi:10.1111/j.1530-0277.2012.01917.x
SP  - 1A
EP  - 152A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8–10, 2011
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - J Cachexia Sarcopenia Muscle
VL  - 2
IS  - 4
SN  - 9783826334054
UR  - https://doi.org/10.1007/s13539-011-0045-3
DO  - doi:10.1007/s13539-011-0045-3
SP  - 209
EP  - 261
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Developmental Medicine & Child Neurology
JA  - Dev Med Child Neurol
VL  - 57
IS  - s1
SN  - 9783826334054
UR  - https://doi.org/10.1111/dmcn.12655
DO  - doi:10.1111/dmcn.12655
SP  - 18
EP  - 65
PY  - 2015
ER  - 
